Charting the Course in Sequencing Antibody-Drug Conjugates in Breast Cancer

Based on the unprecedented results observed in recent clinical trials, antibody-drug conjugates (ADCs) have revolutionized the treatment algorithm of metastatic breast cancer (mBC). The strategy of sequencing different ADCs in other lines of therapy is highly attractive, but the proportion of patien...

Full description

Bibliographic Details

Published in:	Biomedicines
Main Authors:	Giuseppe Saltalamacchia, Rosalba Torrisi, Rita De Sanctis, Giovanna Masci, Chiara Miggiano, Mariangela Gaudio, Chiara Benvenuti, Flavia Jacobs, Riccardo Gerosa, Armando Santoro, Alberto Zambelli
Format:	Article
Language:	English
Published:	MDPI AG 2024-02-01
Subjects:	metastatic breast cancer antibody-drug conjugates therapy sequencing trastuzumab-deruxtecan sacituzumab govitecan novel ADCs
Online Access:	https://www.mdpi.com/2227-9059/12/3/500